R&D agreement will focus on UV systems
Canada-based Trojan Technologies Inc. (TSE/TUV) has entered into an agreement with N.V. PWN Water Supply Company North-Holland (PWN) to collaborate in the research, design, optimisation and installation of ultraviolet (UV) treatment systems.
'Drinking water contamination is a growing global concern,' said Hank Vander Laan, President and CEO of Trojan Technologies. 'We are extremely pleased to have established this relationship with PWN, a recognized leader in the treatment and supply of top quality drinking water in Europe, to implement a lasting solution to a difficult micropollutant problem. Global awareness of contaminant pollution continues to grow and it is important that we develop and provide new solutions to these risks. We believe that as the public and governments embrace the need for more advanced treatment of drinking water, a very significant market will emerge.'
Mr. P.C. Kamp, Director of Production for N.V. PWN said, 'Trojan has fully demonstrated its abilities in both research and development and we look forward to combining their research and design capabilities with our expertise in advanced drinking water treatment.'
The project, expected to be completed over two and half years, has three phases. The first two involve extensive joint R&D, involving piloting and prototype testing at a major municipal drinking water treatment plant in the Netherlands.
PWN has conducted its own research on the effectiveness of ultraviolet light
and advanced oxidation for over five years. The combined effort, leveraging
the unique expertise of both parties, will optimise the configuration of the
The third phase is the final equipment manufacture, delivery and installation of UV disinfection and advanced oxidation equipment. The agreement provides that Trojan will retain all intellectual property rights associated with the project.
The drinking water treatment plant, located at Andijk serves approximately 500,000 people and treats approximately 25M metres³ of water per year. It is expected to be the largest installation involving UV technology in Europe and is the first of its kind to treat micropollutants.
'Ultraviolet systems have, for some time, been proven as an effective barrier
against a wide range of pathogens, including Ecoli, Cryptosporidium and Giardia,'
said Marvin DeVries, Executive Vice President and Chief Operating Officer for
'This project will optimize the design of a UV treatment system, using Advanced Oxidation, effectively treating a much wider range of contaminants, which with extended exposure, may be harmful to human health,' he added.